↑↓ navigate open esc close
Spain PLACE contract award · ocds-ted-158353-2025-2

Spain – Various medicinal products – Suministro de los principios activos denominados "Upadacitinib 45mg oral" Y "Risank

Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín awarded €244K to ABBVIE SPAIN, S.L. for Construction & Public Works in March 2025 — one of 265 awards this buyer has made, above its typical award size.

11 Mar 2025
Award date
€244K
Contract value
265 Awards
€165K Avg award
Above vs typical

Winning supplier

ABBVIE SPAIN, S.L.
139 Awards
45 Buyers
€95.7M Total won

Contract description

Spain – Various medicinal products – Suministro de los principios activos denominados "Upadacitinib 45mg oral" Y "Risankizumab 360mg/2,4ml".

Premium

Related awards · Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín

265 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

221 more awards from this buyer · full history & CSV export

Premium

Other wins · ABBVIE SPAIN, S.L.

139 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín and ABBVIE SPAIN, S.L. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up